Pharmaceutical

‘A target on my back’: New survey shows racism is a hug...

In a new survey, 80% of nurses said they have seen or experienced racism from pa...

Opinion: Listen: Ezekiel Emanuel explains why cancer pa...

In the new episode of the "First Opinion Podcast," oncologist Ezekiel Emanuel ar...

Sacklers win appeal that shields them from opioid lawsu...

A federal appeals court ruled Tuesday Purdue Pharma can shield its owners from t...

Sen. Elizabeth Warren probes abortion access amid state...

Sen. Elizabeth Warren (D-Mass.) is launching a fresh round of questioning on sta...

STAT+: Pharmalittle: Pfizer touts study data for hemoph...

A report by nonpartisan congressional researchers suggests there are at least so...

STAT+: European regulatory panel weighing against appro...

A European regulatory panel has taken a negative view of whether an ALS treatmen...

Opinion: More hospitals are offering child care. But th...

“Basically no one leaves that utilizes the child care center."

STAT+: Lured by a bigger payday, a medical device maker...

Lured by a bigger payday from insurance, a medical device maker sold fake plasti...

STAT wants to know your pick for a great summer read or...

We want to hear from you! We're gathering recommendations for books and podcasts...

Opinion: In defense of being ‘Cali sober’

Hardcore proponents of abstinence-based recovery, such as Alcoholics Anonymous, ...

STAT+: Just how vulnerable is Medicare drug negotiation...

A new report suggests there are at least some parts of the law setting up Medica...

Valneva seeks Health Canada approval for chikungunya va...

The single-shot vaccine is intended for persons aged 18 years and above.

Roche Canada and pCPA conclude talks for Vabysmo eye th...

Vabysmo helps treat neovascular (wet) age-related macular degeneration (AMD) and...

Sun Pharma and Philogen sign licence agreement for anti...

Sun Pharma will commercialise Nidlegy in three countries to treat skin cancers.

Early signals suggest oral SERD’s potential for more br...

The company is presenting exploratory results at ASCO, which demonstrates new us...

US companies drive 2023 drug launches positioned for bl...

Notably, American pharmaceutical mega-cap companies take the lead, with 80% repr...